White House Pharmacy Misconduct Allegations

White House pharmacy under the Trump administration faced improper drug provisioning and misuse of funds, according to a Pentagon report. The pharmacy failed to comply with federal guidelines, providing prescription drugs to ineligible staffers and using excessive amounts of expensive brand-name medications. The report highlighted risks to patient health and safety, covering the period from 2009 to 2018, focusing on the 2017-2019 administration under Trump.